Business R&D investment set to grow by 5 per cent for next three years

Research by the European Union's Joint Research Centre (JRC) suggests that business investment in research and development (R&D) will increase by as much as five per cent per year for the next three years.

Increasing R&D investment is a key component of the Lisbon Strategy, and the blueprint for European innovation. The expert group report chaired by former Finnish Prime Minister Esko Aho explicitly refers to the Lisbon goal of increasing investment in research to three per cent of GDP. In 2005, only 1.91 per cent of GDP was spent on R&D in the EU.

Should this increase be mirrored across the board, then the figure could rise to almost 2.2 per cent of GDP spent on R&D by 2010 - short of Lisbon targets but still a huge improvement.

The European Commission's Seventh Framework Programme (FP7) will see huge increases in its budget compared to previous Framework Programmes. This money will go directly to research, but money also has to come from business. "If we are to reach our objective of investing 3 per cent of GDP in research and development, we need increased investment by the private sector," said European Commissioner for Science and Research, Janez Potocnik.

"For this reason the results of this survey are encouraging. We need to maintain and reinforce our efforts at European and national level to make Europe an attractive place for companies to carry out their research. The Commission will be coming forward with some more ideas in this area in autumn 2006," continued the Commissioner.

Perhaps unsurprisingly, companies prefer to invest in their own countries. The largest investors in R&D continue to be the largest economies - Germany, France and the UK. However, the skill of workforce and access to markets were found by the report to be significant factors. Meanwhile, cost of workforce was low. For EU companies, the US is the most attractive non-EU state to invest, followed by India and China.

Perhaps more importantly, "The incentives to increase R&D investment most often cited in the responses are: changes in market demand for new products and services, changes in technological opportunities, and changes in company turnover or profit. Changes in the availability and labour costs of researchers are the least often cited incentives for increasing R&D investment," reads the report.

This shows that companies are pragmatic, and respond to market and economic need. This also demonstrates the importance of developing lead markets for technological innovations, to encourage further research, as cited in the expert group report into innovation.

The survey questioned 449 firms in ten sectors: automobiles and parts; chemicals; electronic and electrical equipment; engineering and machinery; food producers and processors; health; IT hardware; pharmaceuticals and biotechnology; steel and other metals; and support services

For further information, please visit the European Commission's innovation portal and read the expert group report:
http://ec.europa.eu/invest-in-research/index_en.htm

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...